Effects of efgartigimod treatment on humoral and cellular immune responses: analysis of T-cell-dependent antibody response in cynomolgus monkeys

Efgartigimod is a human IgG1 antibody Fc fragment that reduces IgG levels through neonatal Fc receptor blockade. This study evaluated whether efgartigimod affects the generation of T-cell-dependent antibodies and cellular immune responses to keyhole limpet hemocyanin (KLH) immunization in non-human...

Повний опис

Бібліографічні деталі

Автори:	Ornella Binazon, Mario Cocco, Daniel Thwaites, Christopher Cooper, Mahan Moshir, Peter Vanhoenacker, Dieter Defever, Ariëlla Van de Sompel, Sophie Steeland, Gwenda Pynaert, Peter Ulrichts, Judith Baumeister
Формат:	Artigo
Мова:	Inglês
Опубліковано:	Taylor & Francis Group 2025-12-01
Серія:	Journal of Immunotoxicology
Предмети:	Efgartigimod neonatal Fc receptor immunoglobulin G keyhole limpet hemocyanin immune response antibody
Онлайн доступ:	https://www.tandfonline.com/doi/10.1080/1547691X.2025.2459934
Теги:	Додати тег Немає тегів, Будьте першим, хто поставить тег для цього запису!